Clinical Trials Browser

Phase 2/3 × abiraterone × Clear all

NCT04787744 2026-04-08

VA STARPORT

Phase 2/3 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms

NCT00268476 2023-04-18

STAMPEDE

Phase 2/3 Active not recruiting

11,992 enrolled

Prostatic Neoplasms

NCT03295565 2022-04-15

OSTRICh

Phase 2/3 Completed

Neoplasm Metastasis